Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001437749-26-000616 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
4,170
Total Value
$43,543.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A Common Stock | โ | Jan 5, 2026 | Sale | 3,670 | $10.35 | $37,978.26 | 160,722 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jan 5, 2026 | Sale | 500 | $11.13 | $5,564.90 | 160,222 | Direct | โ | View Details |